Pharmacists in Cedar Park, Texas


61 Pharmacists found in Cedar Park
female pharmacist

Rupal Patel


Pharmacist
2916 Zambia Dr, Cedar Park, TX 78613
512-659-1751    

female pharmacist

Dr. Sarah Mai Nguyen, PHARMD


Pharmacist - Geriatric
701 N Vista Ridge Blvd Apt 21304, Cedar Park, TX 78613
214-448-0099    

female pharmacist

Seonsuk Kim


Pharmacist
710 N Bell Blvd, Cedar Park, TX 78613
512-250-0867    



female pharmacist

Sheneil Roberts, PHARMD


Pharmacist
101 Commercial Pkwy, Cedar Park, TX 78613
512-219-0724    

female pharmacist

Ms. Sothda Kim Penn, PHARMD


Pharmacist
1495 Cypress Creek Rd, Cedar Park, TX 78613
512-401-2151     512-401-0891

female pharmacist

Ms. Stephanie Lynn Sisley, R.PH.


Pharmacist
2800 E Whitestone Blvd, Cedar Park, TX 78613
512-528-0251     512-528-0400

male pharmacist

Dr. Steven Neil Delao, PHARMD RPH


Pharmacist
351 Cypress Creek Rd Ste 100, Cedar Park, TX 78613
512-827-7393    

male pharmacist

Thomas Lanford


Pharmacist
1400 Cypress Creek Rd, Cedar Park, TX 78613
512-506-9112     512-506-9127

male pharmacist

Timothy Kibiwott Cheum, PHARM D.


Pharmacist
201 Walton Way, Cedar Park, TX 78613
512-528-8794    

male pharmacist

Tony Diep


Pharmacist
4601 183a Toll Rd, Cedar Park, TX 78613
512-690-9083    

female pharmacist

Veronica Chang


Pharmacist
2800 E Whitestone Blvd, Cedar Park, TX 78613
512-582-0150     512-528-0400

female pharmacist

Veronica Coker, PHARM.D.


Pharmacist
1505 W Whitestone Blvd, Cedar Park, TX 78613
512-335-5765    

female pharmacist

Zeerak Razvi


Pharmacist
1950 Bagdad Rd, Cedar Park, TX 78613
512-528-1193    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.